Corrigendum to: A phase II evaluation of Pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: A Gynecologic Oncology Group Study [Gynecol Oncol 133 (2014) 537-541]


Journal Article

Full Text

Duke Authors

Cited Authors

  • Campos, SM; Brady, WE; Moxley, KM; O'Cearbhaill, RE; Lee, PS; DiSilvestro, PA; Rotmensch, J; Rose, PG; Thaker, PH; O'Malley, DM; Hanjani, P; Zuna, RE; Hensley, ML

Published Date

  • January 1, 2014

Published In

Volume / Issue

  • 135 / 3

Start / End Page

  • 624 -

Electronic International Standard Serial Number (EISSN)

  • 1095-6859

International Standard Serial Number (ISSN)

  • 0090-8258

Digital Object Identifier (DOI)

  • 10.1016/j.ygyno.2014.08.011

Citation Source

  • Scopus